ATRC - AtriCure, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Mason,
United States
Type: Equity
ATRC price evolution
ATRC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $106.03 | $64.97 | $84.31 | |
| Short term investments | $7.99 | $40.99 | $52.98 | |
| Net receivables | $54.91 | $55.57 | $55.32 | $52.5 |
| Inventory | $76.55 | $73.65 | $71.94 | $67.9 |
| Total current assets | $269.29 | $252.85 | $245.22 | $266.25 |
| Long term investments | ||||
| Property, plant & equipment | $49.64 | $46.2 | $46.23 | $46.76 |
| Goodwill & intangible assets | $295.02 | $296.9 | $298.77 | |
| Total noncurrent assets | $344.42 | $346.4 | $347.69 | |
| Total investments | $7.99 | $40.99 | $52.98 | |
| Total assets | $615.07 | $597.27 | $591.63 | $613.93 |
| Current liabilities | ||||
| Accounts payable | $103.45 | $26.67 | $28.99 | $27.35 |
| Deferred revenue | ||||
| Short long term debt | $2.54 | $2.54 | $2.53 | |
| Total current liabilities | $74.43 | $61.23 | $61.25 | $74.57 |
| Long term debt | $61.87 | $72.78 | $72.82 | $71.96 |
| Total noncurrent liabilities | $73.96 | $74.06 | $73.19 | |
| Total debt | $75.32 | $75.36 | $74.49 | |
| Total liabilities | $150.05 | $135.19 | $135.31 | $147.76 |
| Shareholders' equity | ||||
| Retained earnings | -$386.19 | -$378.33 | -$370.33 | -$357.06 |
| Other shareholder equity | -$0.15 | -$0.57 | -$0.7 | -$0.99 |
| Total shareholder equity | $462.08 | $456.31 | $466.17 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $84.31 | $58.1 | $43.65 | $41.94 |
| Short term investments | $52.98 | $63.01 | $75.44 | $202.27 |
| Net receivables | $52.5 | $42.69 | $33.02 | $23.15 |
| Inventory | $67.9 | $45.93 | $38.96 | $35.03 |
| Total current assets | $266.25 | $215.21 | $196.08 | $306.74 |
| Long term investments | $51.51 | $104.34 | $14.18 | |
| Property, plant & equipment | $46.76 | $42.62 | $36.17 | $30.2 |
| Goodwill & intangible assets | $298.77 | $274.12 | $277.77 | $362.98 |
| Total noncurrent assets | $347.69 | $370.23 | $419.24 | $407.8 |
| Total investments | $52.98 | $114.52 | $179.77 | $216.45 |
| Total assets | $613.93 | $585.45 | $615.31 | $714.54 |
| Current liabilities | ||||
| Accounts payable | $27.35 | $19.9 | $18.6 | $12.74 |
| Deferred revenue | ||||
| Short long term debt | $2.53 | $5.47 | $1.76 | $8.42 |
| Total current liabilities | $74.57 | $58.39 | $56.45 | $49.14 |
| Long term debt | $71.96 | $65.98 | $73.89 | $65.58 |
| Total noncurrent liabilities | $73.19 | $70.3 | $75.11 | $253.01 |
| Total debt | $74.49 | $74.55 | $75.65 | $74 |
| Total liabilities | $147.76 | $128.69 | $131.56 | $302.14 |
| Shareholders' equity | ||||
| Retained earnings | -$357.06 | -$326.62 | -$280.15 | -$330.35 |
| Other shareholder equity | -$0.99 | -$0.4 | -$0.95 | $0.31 |
| Total shareholder equity | $466.17 | $456.75 | $483.76 | $412.39 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $115.91 | $116.27 | $108.85 | $106.54 |
| Cost of revenue | $29.43 | $27.58 | $26.73 | |
| Gross Profit | $86.79 | $86.84 | $81.27 | $79.81 |
| Operating activities | ||||
| Research & development | $20.42 | $19.84 | $20.8 | |
| Selling, general & administrative | $73.6 | $72.34 | $67.69 | |
| Total operating expenses | $94.2 | $94.01 | $92.19 | $88.48 |
| Operating income | -$7.17 | -$10.92 | -$8.67 | |
| Income from continuing operations | ||||
| EBIT | -$6.14 | -$11.41 | -$7.62 | |
| Income tax expense | $0.32 | $0.25 | $0.18 | $0.37 |
| Interest expense | -$0.39 | $1.61 | $1.68 | $1.8 |
| Net income | ||||
| Net income | -$7.85 | -$8.01 | -$13.27 | -$9.79 |
| Income (for common shares) | -$8.01 | -$13.27 | -$9.79 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $399.25 | $330.38 | $274.33 | $206.53 |
| Cost of revenue | $98.88 | $84.44 | $68.47 | $57.22 |
| Gross Profit | $300.37 | $245.94 | $205.86 | $149.31 |
| Operating activities | ||||
| Research & development | $73.92 | $57.34 | $48.51 | $43.07 |
| Selling, general & administrative | $253.14 | $231.27 | $204.65 | $150.47 |
| Total operating expenses | $327.05 | $288.61 | $335.45 | $193.54 |
| Operating income | -$26.68 | -$42.67 | -$129.59 | -$44.23 |
| Income from continuing operations | ||||
| EBIT | -$22.92 | -$41.21 | $55.3 | -$43.16 |
| Income tax expense | $0.59 | $0.27 | $0.19 | $0.11 |
| Interest expense | $6.92 | $4.99 | $4.92 | $4.88 |
| Net income | ||||
| Net income | -$30.44 | -$46.47 | $50.2 | -$48.16 |
| Income (for common shares) | -$30.44 | -$46.47 | $50.2 | -$48.16 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$8.01 | -$13.27 | -$9.79 | |
| Operating activities | ||||
| Depreciation | $4.53 | $4.45 | $4.18 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $10.39 | $9.27 | $9.31 | |
| Total cash flows from operations | $7.38 | -$21.02 | $4.03 | |
| Investing activities | ||||
| Capital expenditures | -$2.36 | -$2.77 | -$2.79 | |
| Investments | $33.25 | $12.42 | ||
| Total cash flows from investing | $44.93 | $30.89 | $9.64 | -$2.79 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.26 | -$6.15 | $2.62 | |
| Net borrowings | -$0.41 | -$1.72 | -$0.26 | |
| Total cash flows from financing | -$5.34 | $2.85 | -$7.86 | $2.36 |
| Effect of exchange rate | $0.07 | -$0.06 | -$0.11 | $0.11 |
| Change in cash and equivalents | $46.02 | $41.07 | -$19.34 | $3.71 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$30.44 | -$46.47 | $50.2 | -$48.16 |
| Operating activities | ||||
| Depreciation | $14.81 | $11.71 | $10.44 | $9.55 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $35.73 | $28.77 | $28.08 | $22.64 |
| Total cash flows from operations | $4.48 | -$22.14 | -$13.78 | -$19.87 |
| Investing activities | ||||
| Capital expenditures | -$42 | -$16.88 | -$9.75 | -$5.26 |
| Investments | $63.81 | $60.89 | $33.26 | -$151.74 |
| Total cash flows from investing | $21.82 | $44.01 | $23.5 | -$156.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.02 | -$6.16 | -$5.66 | $190.09 |
| Net borrowings | -$0.99 | -$0.9 | -$0.82 | -$0.67 |
| Total cash flows from financing | -$0.03 | -$7.06 | -$7.64 | $189.39 |
| Effect of exchange rate | -$0.06 | -$0.36 | -$0.37 | $0.14 |
| Change in cash and equivalents | $26.21 | $14.45 | $1.71 | $13.46 |
News
Fundamentals
| Market cap | $1.93B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 48.75M |
| Revenue | $447.57M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$38.92M |
| Revenue Q/Q | 17.93% |
| Revenue Y/Y | 17.56% |
| P/E ratio | -49.48 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 4.30 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.80 |
|---|---|
| ROA | -6.44% |
| ROE | N/A |
| Debt/Equity | 0.32 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.62 |
| Quick ratio | 2.59 |